A Genetic Link to Atrial Substrate in Hypertrophic Cardiomyopathy?
- 19 June 2024
- journal article
- editorial
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 10 (7) , 1392-1394
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic CardiomyopathyJACC: Clinical Electrophysiology, 2024
- 2023 ESC Guidelines for the management of cardiomyopathiesEuropean Heart Journal, 2023
- Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic diseaseJournal of Electrocardiology, 2021
- Translational investigation of electrophysiology in hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2021
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive SummaryJACC, 2020
- Left atrial voltage mapping: defining and targeting the atrial fibrillation substrateJournal of Interventional Cardiac Electrophysiology, 2019
- Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic CardiomyopathyCirculation, 2017
- Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysisHeart, 2016
- Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progressionEP Europace, 2010